A cholesterol-rich diet accelerates the negativization of sputum culture in pulmonary tuberculosis: a controlled clinical trial

C. Pérez-Guzmán, M. H. Vargas, N. Bazavilvazo, F. Quiñonez, A. Aguilar, A. Torres, H. Villarreal, J. Loeza, A. García, I. Estrada, V. López, L. Infante (Mexico DF, Mexico)

Source: Annual Congress 2002 - Management of tuberculosis in adults and children
Session: Management of tuberculosis in adults and children
Session type: Oral Presentation
Number: 3517
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Pérez-Guzmán, M. H. Vargas, N. Bazavilvazo, F. Quiñonez, A. Aguilar, A. Torres, H. Villarreal, J. Loeza, A. García, I. Estrada, V. López, L. Infante (Mexico DF, Mexico). A cholesterol-rich diet accelerates the negativization of sputum culture in pulmonary tuberculosis: a controlled clinical trial. Eur Respir J 2002; 20: Suppl. 38, 3517

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 376
Year: 2011



The use of induced sputum in clinical trials
Source: Eur Respir J 2002; 20: 47S-50S
Year: 2002


The effect of azithromycin on sputum inflammatory markers in bronchiectasis – analysis of a randomized controlled trial
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019



A three-month old pulmonary tuberculosis case with positive sputum culture
Source: Eur Respir J 2004; 24: Suppl. 48, 397s
Year: 2004

Predictors of delayed sputum culture conversion in tuberculosis patients
Source: Annual Congress 2011 - Clinical tuberculosis
Year: 2011


A randomized study of bronchoscopic blockade of the affected part of a lung as a part the complex treatment of patients with drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Factors associated with sputum culture conversion in patients with pulmonary tuberculosis
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017


A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis with treatment failure
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013

A double blind randomized study of aminoglycoside infusion with combined therapy for pulmonary mycobacterium avium complex disease
Source: Annual Congress 2006 - Clinical epidemiology of tuberculosis
Year: 2006


The debacillisation rate during controlled anti-TB therapy
Source: Annual Congress 2005 - Information for the active clinician
Year: 2005


A randomized study of the bronchoscopic valve blockade of the affected part of the lung in the complex treatment of patients with cavitary drug-resistant pulmonary tuberculosis
Source: Annual Congress 2012 - Tuberculosis: invasive diagnostic and therapeutic interventions
Year: 2012

Role of N-acetylcysteine(NAC) in preventing development of anti tuberculosis therapy(ATT) induced liver injury in pulmonary tuberculosis(PTB) patients, a simple randomized single blind clinical trial
Source: Virtual Congress 2020 – Tuberculosis: part 2
Year: 2020




Clinical significance of low serum isoniazid level among the patients with drug-sensitive pulmonary tuberculosis who showed delayed smear or culture conversion.
Source: International Congress 2018 – New developments in tuberculosis
Year: 2018



Yield of examining repeated sputum specimens in diagnosis of pulmonary tuberculosis: how many sputum samples are adequate?
Source: Eur Respir J 2004; 24: Suppl. 48, 33s
Year: 2004

Long-term efficacy of a home-based airway clearance programme to improve cough severity in patients with bronchiectasis:a randomised controlled trial>
Source: International Congress 2019 – Advances in bronchiectasis and non-TB mycobacterial infections
Year: 2019




Enhanced clinical improvement in pulmonary tuberculosis patients with antioxidant supplementation: a preliminary report
Source: Eur Respir J 2003; 22: Suppl. 45, 40s
Year: 2003

A cross-over study to compare the Lung Flute™ to hypertonic saline inhalation about the performance of inducing sputum for the diagnosis of pulmonary tuberculosis
Source: International Congress 2015 – Management of TB: a patient focus
Year: 2015


Supplementation of N-acetylcysteine as an adjuvant in treatment of newly diagnosed pulmonary tuberculosis patients: A prospective, randomized double blind, placebo controlled study
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection: diagnosis and treatment
Year: 2013

Safety and benefit of adjunctive systemic corticosteroid therapy in the management of severe, smear positive pulmonary tuberculosis (SSP-PTB); an interim analysis of a randomized controlled trial
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


To compare the diagnostic accuracy of acid fast bacilli smear results of induced sputum with broncho-alveolar lavage among pulmonary tuberculosis cases keeping acid fast bacilli culture as gold standard in a resource limited setting in non expectorating patients
Source: International Congress 2016 – Microbiology: bronchoalveolar lavage (BAL) and PCR
Year: 2016